ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MHRA allows HAE patients early access to berotralstat pharmatimes
November 04, 2020Patients with hereditary angioedema (HAE) living in the UK will get early access to BioCryst's berotralstat before the drug is officially approved for this indication by the European Commission.
Pharma Sources Insight January 2025
